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OPEN
SHORT COMMUNICATION
The chromosome 3q25 locus associated with fetal adiposity
is not associated with childhood adiposity
R Chawla1,6, DR McCance2,3,6, S McKenna3, IS Young2, CC Patterson2, J Rangarajan4, AC Reisetter4, LL Armstrong5, LP Lowe4,
BE Metzger5, MG Hayes5, DM Scholtens4 and WL Lowe5
Increased newborn adiposity is associated with later adverse metabolic outcomes. Previous genome-wide association studies
(GWAS) demonstrated strong association of a locus on chromosome 3 (3q25.31) with newborn sum of skinfolds, a measure of
overall adiposity. Whether this locus is associated with childhood adiposity is unknown. Genotype and sum of skinfolds data were
available for 293 children at birth and age 2, and for 350 children at birth and age 6 from a European cohort (Belfast, UK) who
participated in the Hyperglycemia and Adverse Pregnancy Outcome GWAS. We examined single nucleotide polymorphisms (SNPs)
at the 3q25.31 locus associated with newborn adiposity. Linear regression analyses under an additive genetic model adjusting for
maternal body mass index were performed. In both cohorts, a positive association was observed between all SNPs and sum of
skinfolds at birth (P= 2.3 × 10− 4, β= 0.026 and P= 4.8 × 10− 4, β= 0.025). At the age of 2 years, a non-signiﬁcant negative association
was observed with sum of skinfolds (P= 0.06; β =− 0.015). At the age of 6 years, there was no evidence of association (P= 0.86;
β= 0.002). The 3q25.31 locus strongly associated with newborn adiposity had no signiﬁcant association with childhood adiposity
suggesting that its impact may largely be limited to fetal fat accretion.
Nutrition & Diabetes (2014) 4, e138; doi:10.1038/nutd.2014.35; published online 22 September 2014
INTRODUCTION
Fat at birth is unique to humans among primates, suggesting that a
recently evolved genetic component accounts for this difference.1
Body fat accumulated during intrauterine development in humans
is thought to serve as an energy source to support growth of the
large human newborn brain in the early neonatal period.1 As such,
subcutaneous fat provides adaptive advantages and is thought to
be under positive selection. However, high or low body fat at birth
is associated with increased morbidity in the ﬁrst year of life as well
as an increased susceptibility to poor metabolic and/or cardiovas-
cular health later in life.2,3 While maternal fuels such as glucose and
triglycerides impact fetal fat accretion, genetic factors also
contribute.4–8 A locus between CCNL1 and LEKRI on chromosome
3 (3q25.31) was previously shown to be associated with
birthweight,5 but our recent genome-wide association study
(GWAS) performed in a multi-ancestry cohort of newborns revealed
this locus was much more strongly associated with newborn sum of
skinfolds (P=1.52× 10− 14), a measure of newborn adiposity, than
with birthweight (P=5.72×10− 7).8 The goal of the present study
was to determine whether this same locus is associated with
adiposity at later points during childhood.
MATERIALS AND METHODS
The Hyperglycemia and Adverse Pregnancy Outcome (HAPO)
Study was an international multi-center epidemiologic study that
examined levels of maternal glucose tolerance and risk of adverse
pregnancy outcomes. Study methods have been previously
described.9 Brieﬂy, eligible women underwent a 75 g oral glucose
tolerance test between 24 and 32 weeks gestation. Using
standardized methods and procedures, maternal height, weight,
and blood pressure were measured, and maternal demographic
information was collected. At delivery, cord blood was collected
for measurement of newborn glucose, C-peptide and DNA
extraction. Using standardized methods and equipment, neonatal
anthropometric measurements were obtained within 72 h of birth,
including head circumference, birth length, birthweight and
skinfold thickness measured at the ﬂank, triceps and subscapular
regions. HAPO participants and their offspring from the Belfast,
Northern Ireland center were invited to participate in the HAPO
Family Study in which offspring were examined at the ages of 2
and 6 years. Measurements included weight, height, head
circumference, mid-arm circumference, and triceps, subscapular,
and suprailiac skinfold thickness.10 For genetic analyses, individual
skinfold measurements and their sum were log transformed.
In the GWAS examining newborn size, HAPO newborns from
four ancestries were genotyped using Illumina genomewide single
nucleotide polymorphism (SNP) arrays (Illumina, Inc., San Diego,
CA, USA). Details of genotyping platform selection, genotype
calling algorithms, quality control and imputation procedures, and
estimating population substructure were previously reported.8
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We examined the association of four SNPs at this locus with
sum of skinfolds, a measure of adiposity, among Belfast HAPO
offspring at 2 and 6 years of age using linear regression analyses
(SNPTESTv2) with an additive model, adjusting for ancestry
(principal components 1 and 2), newborn gender, gestational
age at delivery, parity, and maternal age, body mass index (BMI),
height, mean arterial blood pressure, smoking status and alcohol
intake at the time of oral glucose tolerance test. Results are
reported as a nominal P value and a β regression coefﬁcient. All
other analyses were conducted in SAS 9.3 (SAS Institute, Cary,
NC, USA).
RESULTS
Genotype and phenotype data were available at birth and age 2
for 293 children and at birth and age 6 for 350 children (Table 1);
270 children were common between the two cohorts. Four SNPs
at the chromosome 3q25.31 locus that are in strong linkage
disequilibrium (lowest pairwise r2 = 0.93), rs10049088, rs1482853,
rs17451107 and rs900400, were previously shown to be the SNPs
most highly associated with sum of skinfolds in a cohort of HAPO
newborns.8 The association and direction of effect between one of
these SNPs, rs900400, and sum of skinfolds as well as individual
skinfold thicknesses in the cohorts of 2- and 6-year-olds from the
Belfast HAPO Family Study are shown in Table 2.
A positive association was observed between rs900400 and
newborn sum of skinfolds among the 293 children in the cohort of
2-year olds (P=4.8× 10− 4; β=0.025), and 350 children in the cohort
of 6-year olds (P=2.8× 10− 4; β=0.024). In contrast, at age 2 years
and 6 years no association was observed between sum of skinfolds
and rs900400 (P=0.06, β=− 0.015 at age 2; P=0.86, β =0.002 at
age 6). Although rs900400 demonstrated a marginal, albeit non-
signiﬁcant, association with sum of skinfolds at age 2 years, the
direction of effect was opposite to that observed in the newborns.
Similar analyses were performed examining the association of
rs900400 with measurements of the ﬂank/suprailiac, triceps and
subscapular skinfolds (Table 2). A positive association was observed
between rs900400 and individual skinfold measurements at birth
among the 293 children in the cohort of 2-year olds (triceps,
P=3.4× 10− 3; subscapular, P=2.0× 10− 4; ﬂank, P=5.0 × 10−3), and
350 children in the cohort of 6-year olds (triceps, P=1.8× 10− 3;
subscapular, P=5.0 ×10-4; ﬂank, P=1.0 ×10− 3). For the suprailiac
and subscapular skinfold thicknesses, an association with rs900400
was not seen at either age 2 (P=0.14 and P=0.52, respectively) or
age 6 (P=0.70 and P=0.98, respectively). However, in the cohort of
2-year olds, rs900400 was weakly associated with triceps skinfold
thickness at age 2 (P=0.03). However, the direction of effect was
again opposite to that observed in newborns. There was no
evidence for association of rs900400 with triceps skinfold thickness
at age 6 (P=0.97).
DISCUSSION
Excess adiposity at birth, which is recognized as a risk factor for
peri- and postnatal complications as well as childhood obesity and
adverse metabolic health outcomes during adulthood, is inﬂu-
enced by both environmental and genetic factors.11,12 Multiple
maternal factors inﬂuence the intrauterine environment, including
maternal BMI, height, blood pressure, nutrition, alcohol consump-
tion, smoking and socioeconomic background, with maternal
metabolic factors also having an important impact on fetal
adiposity.11,13 In addition to maternal metabolism, fetal genetics
also plays an important role in fetal fat accretion. We and others
have previously used GWAS to identify genes associated with
birthweight and/or newborn sum of skinfolds.5,6,8 A highly
signiﬁcant and reproducible ﬁnding was the association of SNPs
within the chromosome 3q25.31 locus with newborn adiposity as
reﬂected by newborn sum of skinfolds or ponderal index.5,6,8 In
this report, we now demonstrate that association of this locus with
measures of adiposity is no longer evident at ages 2 and 6 years,
consistent with the recent observation that this locus is no longer
associated with birthweight by age 2 months.6 Association of this
locus with sum of skinfolds, driven primarily by skinfold thickness
at the triceps, approached signiﬁcance in the cohort of 2-year olds,
but this association was in the opposite direction to that observed
in newborns. In the cohort of 6-year olds, there was no evidence of
association of rs900400 with any of the individual skinfolds.
Together with the results of previous studies, these new ﬁndings
suggest that genetic variation within the 3q25.31 locus contributes
to fetal fat accretion but not to early childhood adiposity.
As in newborns, childhood adiposity is under both environ-
mental and genetic control. Both low and normal birthweight
newborns with rapid postnatal weight gain during the ﬁrst 2 years
of life have higher body fat and lower lean body mass and, during
adulthood, higher body weight and fat.14,15 Prevention of rapid
postnatal growth in such individuals may prevent development of
an obese adult phenotype.2 Genetic variation is another important
determinant of childhood adiposity. Through GWAS and related
approaches, association of variants within 22 different genetic loci
with childhood BMI or body weight has been demonstrated,16,17
but SNPs in the chromosome 3q25.31 locus have not been
reported. Consistent with that, meta-analyses performed by the
Early Growth Genetics (EGG) Consortium (www.egg-consortium.
org) in European ancestry children failed to demonstrate
association of rs900400 with childhood obesity (deﬁned as BMI
⩾ 95th percentile; P= 0.90).17 Similarly, a previous analysis of data
from the GIANT consortium showed no evidence of association of
the 3q25.31 locus with adult BMI.6
Despite the presence of high-quality genotype and phenotype
data, our study had certain limitations. We have examined a small
cohort of offspring from only one HAPO ancestry and, as a result,
our power to demonstrate an association at age 2 and 6 years was
limited. Thus, we can not rule out an association of SNPs at the
chromosome 3q25.31 locus with early childhood adiposity;
however, if this locus is associated with childhood adiposity, the
association is much weaker than that observed during fetal life
Table 1. Belfast HAPO mother and offspring population characteristics
Cohort with
genotype and
sum of skinfolds
data at birth
and 2 years
Cohort with
genotype and
sum of skinfolds
data at birth
and 6 years
Sample size 293 350
Gestational age at OGTT (week) 29.1± 1.2 29.0± 1.2
Age at OGTT (year) 30.3± 5.2 29.9± 5.3
BMI at OGTT (kg m−2) 28.5± 4.6 28.2± 4.2
MAP at OGTT (mm Hg) 83.7± 7.9 83.3± 8.0
Fasting plasma glucose (mg dl− 1) 83.3± 6.5 83.1± 6.1
1-h plasma glucose (mg dl− 1) 134.9± 29.2 135.1± 29.9
2-h plasma glucose (mg dl− 1) 109.7± 22.1 109.3± 22.3
Gestational age at delivery (week) 40.1± 1.1 40.1± 1.0
Maternal smoking (%) 59 (20.1%) 88 (25.1%)
Male offspring (n, %) 132 (45.1%) 169 (48.3%)
Primiparous births (n, %) 158 (53.9%) 175 (50.0%)
Offspring birth weight (g) 3455.1± 505.1 3457.3± 503.9
Offspring birth length (cm) 50.9± 2.1 50.8± 2.2
Head circumference (cm) 35.1± 1.3 35.2± 1.3
Fat mass (%) 12.1± 3.5 12.1± 3.5
Sum of skinfolds at birth (mm)* 12.7, 3.2 12.6, 3.1
Sum of skinfolds at 2 years (mm)* 25.4, 7.1
Sum of skinfolds at 6 years (mm)* 22.5, 9.9
Abbreviations: BMI, body mass index; MAP, mean arterial blood pressure;
OGTT, oral glucose tolerance. ± indicates standard error. *Medians and
interquartile ranges are reported for sum of skinfolds measurements
because of skewed distributions.
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and does not alter our conclusion that the chromosome 3 locus
primarily inﬂuences fetal fat accretion. Similarly, we were not able
to assess directly whether this locus is associated with measures of
obesity in older children and adolescents, but previous studies of
the genetics of childhood obesity have failed to demonstrate an
association.16,17
In summary, we have demonstrated that SNPs within the
chromosome 3q25.31 locus, which exhibit strong association
across multiple ancestry groups with measures of newborn
adiposity,5,6,8 do not have a clear association with early childhood
adiposity among European ancestry HAPO offspring.
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Table 2. Association of the T Allele of rs900400 with Belfast offspring sum of and individual skinfold thicknesses at birth, 2 years and 6 years
2-years old cohort (n= 293) 6-years old cohort (n= 350)
Newborn 2 years Newborn 6 years
Skinfold AF P-value Beta (s.e.) P-value Beta (s.e.) AF P-value Beta (s.e.) P-value Beta (s.e.)
Sum 0.64 4.8 × 10− 4 0.0248 (0.0071) 0.06 − 0.0149 (0.0077) 0.63 2.8 × 10− 4 0.0235 (0.0064) 0.86 0.0019 (0.0108)
Triceps 0.64 3.4 × 10− 3 0.0215 (0.0073) 0.03 − 0.0160 (0.0074) 0.63 1.8 × 10− 3 0.0206 (0.0065) 0.97 − 0.0004 (0.0091)
Subscapular 0.64 2.0 × 10− 4 0.0288 (0.0077) 0.52 − 0.0064 (0.0099) 0.63 5.0 × 10− 4 0.0246 (0.0070) 0.98 0.0003 (0.0128)
Flank/Suprailiac 0.64 5.0 × 10− 3 0.0232 (0.0083) 0.14 − 0.0170 (0.0114) 0.63 1.0 × 10− 3 0.0246 (0.0076) 0.70 0.0056 (0.0105)
Abbreviation: AF, allele frequency (T allele of rs900400). Beta-regression coefﬁcient with logarithmically transformed sum of skinfolds as dependent variable
and SNP included in an additive genetic model. Covariates included in the model were age, ancestry, gender, gestational age at delivery, parity, maternal
smoking status and alcohol intake during pregnancy, maternal age, body mass index, height and mean arterial blood pressure at the time of oral glucose
tolerance test. exp(β) represents the multiplicative effect on sum of skinfolds associated with each copy of the allele after adjustment for all covariates.
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